Table 1 Baseline characteristics of study participants
Variables | Total (N = 1,952) |
|---|---|
Demographic and clinical characteristics | |
Age (years) | 71.4 ± 8.7 |
Female | 1,126 (57.7) |
Duration of education (years) | 12.1 ± 4.7 |
Diagnosis | |
CU | 729 (37.4%) |
MCI | 1,223 (62.6%) |
Ligand type | |
18F-Florbetaben | 566 (29.0%) |
18F-Flutemetamol | 1386 (71.0%) |
Global Centiloid | 42.6 ± 52.0 |
APOE ε4 carrier (missing N = 37) | 677 (35.4%) |
Diagnosis of hypertension (missing N = 22) | 955 (49.5%) |
Diagnosis of diabetes mellitus (missing N = 22) | 409 (21.2%) |
ICV (cm3) | 1,320 ± 130 |
BP measurements per participant | |
Observation period (months) | 37.2 ± 18.7 |
The average of intervals between BP values (months) | 3.2 ± 1.8 |
Number of BP values | 14.6 ± 12.6 |
SBP parameters (mm Hg) | |
Mean SBP | 130.0 ± 12.0 |
SD of SBP | 12.2 ± 4.2 |
DBP parameters (mm Hg) | |
Mean SBP | 69.6 ± 8.0 |
SD of SBP | 7.8 ± 2.7 |